Elixinol Wellness Makes Key Appointments To Leadership Team
New hires strengthen commercial and R&D capabilities to drive growth initiatives and product innovation
News provided by
Share this article
Elixinol Wellness or the
Company)
(ASX:EXL;OTCQB:ELLXF), a global leader in the hemp derived CBD industry, innovating, and selling hemp derived CBD products, is pleased to announce the appointment of Rob Hasselman as President Americas and Beata Silber as Global Head of R&D and Innovation.
The appointments are designed to drive the Company s transformation to being a global wellness business and follow a substantial body of work to reposition the business to achieve revenue growth and an accelerated path to profitability.